Yungjin Pharm. Co., Ltd. (003520.KS) KSC

1,299.00

+30(+2.36%)

Updated at June 02 03:30PM

Currency In KRW

Valuation

Market Cap389.03B
Enterprise Value454.6B
P/E Ratio-68.15
PEG Ratio-0
Price/Sales Ratio0.94
Price/Book Ratio2.68
Enterprise/Revenue1.25
Enterprise/EBITDA42.27

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.01
Operating Margin-0

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.04

Income Statement

Revenue254.26B
Revenue/Share1,388.47
Gross Profit75.86B
EBITDA12.2B
Net Income-227.66M
Diluted EPS-1.24

Balance Sheet

Total Cash6.27B
Total Cash/Share34.26
Total Debt85.15B
Total Debt/Equity0.96
Current Ratio1.66
Book Value Per Share485.57

Price History

52-Week Change-40.14
52-Week High2,450
52-Week Low1,203
Moving Average 50 Days1,673.52
Moving Average 200 Days1,895.59

Statistics

Average Volume442,633
Shares Outstanding182.89M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor563:500
Last Split DateJune 18, 2010